查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1994094

气道支架市场：全球市场按产品类型、材料、应用和销售管道分類的预测 - 2026-2032 年

Airway Stent Market by Product Type, Material, End Use, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，气道支架市场价值将达到 2.169 亿美元，到 2026 年将成长至 2.3133 亿美元，到 2032 年将达到 2.912 亿美元，复合年增长率为 4.29%。

主要市场统计数据
基准年 2025 2.169亿美元
预计年份：2026年 2.3133亿美元
预测年份 2032 2.912亿美元
复合年增长率 (%) 4.29%

全面的背景概述揭示了临床需求、设备创新、监管趋势和不断变化的采购重点如何重塑气道支架的决策框架。

气道支架市场已发展成为一个由临床需求、技术创新和商业性演变交织而成的复杂体系。本文旨在为决策者提供背景信息，帮助他们权衡不断变化的患者照护路径、器械设计方案、监管考虑和分销趋势。在从门诊中心到三级医院的所有临床环境中，气道支架的说明不仅关注其短期疗效，也日益重视其对气道通畅性、患者生活品质以及后续医疗用途的长期影响。

器械工程的进步、监管预期以及不断演变的商业化模式，正在从根本上改变气道支架的竞争格局和部署过程。

近年来，气道支架领域发生了翻天覆地的变化，不仅改变了竞争动态，也重新定义了相关人员的期望。支架设计的技术进步，例如药物释放型机制的整合和自膨胀结构的改进，并非仅仅是渐进式的提升，而是创造了全新的临床价值。这些材料和工程创新正日益与先进的影像技术、输送系统以及术前术后通讯协定相结合，共同降低手术操作的差异性，并拓展复杂气道病变的适应症。

2025 年的关税环境促使策略供应链重组，专注于发展国内製造业，并检视整个气道支架生态系统的采购流程。

2025年美国关税的实施，为气道支架价值链上的相关人员带来了新的商业性和营运复杂性。关税带来的成本压力迫使製造商重新评估其原材料和成品组件的筹资策略，这不仅促使他们采取短期成本削减措施，也促使他们进行长期的供应链重组。对于依赖进口金属、聚合物或成品的公司而言，关税促使他们重新评估供应商多元化策略，包括探索替代来源和扩大区域采购，以降低对单一国家依赖的风险。

综合细分洞察揭示了产品类型、材料成分、使用环境和分销管道如何影响临床选择标准、采购行为和商业化路径。

深入了解市场区隔对于协调产品开发、临床证据产生和商业策略至关重要。依产品类型分析可知，球囊扩张型、药物释放型和自扩张式装置之间的差异会影响临床医生的选择标准、手术流程和辅助性治疗方案。在需要精确控制展开和径向力的情况下，球囊扩张型装置通常是首选；而药物释放型支架则可透过药物控制再血管再阻塞风险，因此更需要有关药物洗脱曲线和全身暴露的证据。另一方面，自扩张式设计则优先考虑在弯曲和动态气道中的适应性以及长期支架的形成。材料选择同样重要。复合材料、金属和聚合物基结构在机械性质和生物相容性之间各有优劣。在金属材料中，钴铬合金、镍钛合金和不銹钢的弹性、抗疲劳性和渗透性各不频谱，这会影响输送系统设计和影像通讯协定。聚合物材料可分为生物相容性聚合物和生物可吸收聚合物。生物相容性聚合物可用于长期支架植入，而生物可吸收聚合物则可在无需永久植入的情况下提供临时支撑，从而改变了长期后续观察和安全性方面的考虑。

美洲、欧洲、中东和非洲以及亚太地区的管理体制、采购文化和临床基础设施存在差异，因此需要量身定制的部署路径，这使得战略性的区域差异化至关重要。

区域趋势对产品上市、监管路径和商业策略有显着影响。在美洲，成熟的临床基础设施和一体化的采购组织优先考虑可靠的临床证据、稳定的供应和成本效益。虽然美国的监管要求和医院采购惯例侧重于长期安全数据和高效的物流，但拉丁美洲市场往往更注重价格合理性和能够适应不同医疗机构容量的灵活服务模式。因此，希望在美洲寻求商机的公司必须在证据生成和灵活的商业模式之间取得平衡，以应对不同的支付方环境和医疗采购标准。

结合先进设备工程、实证临床支援和强大商业性能力的公司正在气道支架领域建立可持续的竞争优势。

气道支架领域的主要企业正透过整合产品创新、临床证据投入和卓越商业性执行的整合策略来脱颖而出。一些企业优先进行材料探索和器械架构设计，以提供具有临床差异化性能特征的产品，从而解决临床环境中观察到的特定失效模式。另一些企业则专注于模组化输送系统和临床医生培训项目，以降低手术复杂性并提高在任何医疗机构中的可重复性。同时，多家企业正致力于加强上市后证据和註册登记，以证明其长期治疗效果，并争取被纳入主要医疗机构的医保覆盖范围。

医疗设备製造商可采取的策略重点，透过主导创新、弹性供应链、客製化商业模式和与支付方合作来加速产品推广应用。

产业领导企业应采取多管齐下的策略，将创新重点、实证投资和营运韧性结合。首先，他们应优先考虑产品开发路径，在确保易于给药和长期生物相容性的同时，解决已证实的临床失效模式。投资差异化材料科学和给药机制将有助于在常规和复杂手术中赢得临床医生的青睐。其次，他们应制定分阶段的临床证据计划，从可操作的註册研究入手，逐步推进到能够证明临床显着差异的比较研究。这些证据将有助于加强采购讨论，并促使医疗机构将产品纳入医疗设备采购清单。

检验可操作的策略推理，该方法结合了对临床医生的访谈、采购洞察、监管分析和技术产品审查。

本报告整合了初级和二级调查的调查方法，以全面了解气道支架的现状。初级调查的资料来源包括对呼吸科和介入医学临床医生、医院和门诊中心的采购经理以及製造和分销供应链高管的结构化访谈。这些访谈旨在深入了解影响部署决策的装置性能优先顺序、采购标准和营运限制等方面的实际问题。二级调查则透过涵盖监管指导文件、临床文献和产品技术规范，对技术趋势和安全考量进行了背景分析。

技术、监管和商业性要求的整合决定了哪些组织能够成功地将气道支架创新与持久的临床和组织影响联繫起来。

总之，气道支架领域正处于一个关键的转折点，随着器材创新、临床证据预期和商业性动态的交汇，其应用路径正在重新定义。儘管材料和设计的进步拓展了治疗选择，但监管和采购环境越来越依赖基于可验证的长期疗效和价值的论点。定价环境和分销模式的转变凸显了建立具有韧性的供应链和灵活的商业化模式的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 气道支架市场：依产品类型划分

  • 球囊扩张型
  • 药物释放型支架
  • 自膨胀

第九章 气道支架市场：依材料分类

  • 复合材料
  • 金属
    • 钴铬合金
    • 镍钛诺
    • 不銹钢
  • 聚合物
    • 生物相容性聚合物
    • 生物可吸收聚合物

第十章 气道支架市场：依最终用途划分

  • 门诊手术中心
    • 多学科部门
    • 单次治疗
  • 诊所
    • 循环系统诊所
    • 呼吸系统医疗设备
  • 医院
    • 当地医院
    • 三级医疗保健

第十一章 气道支架市场：依分销管道划分

  • 直销
  • 销售代理
    • 全国
    • 按地区
  • 电子商务
    • OEM平台
    • 第三方平台

第十二章 气道支架市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 气道支架市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 气道支架市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国气道支架市场

第十六章：中国气道支架市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Allium Medical Solutions Ltd.
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Bryan Corporation
  • BVM Medical Limited
  • Cook Medical
  • Ella-CS
  • EndoFlex GmbH
  • Hood Laboratories
  • Leufen Medical GmbH
  • Medi-Globe Corporation
  • Merit Medical Systems Inc.
  • Micro-Tech Endoscopy Co., Ltd.
  • Novatech SA
  • Olympus Corporation
  • PFM Medical
  • Pnn Medical A/S
  • S&G Biotech
  • Sino Medical Sciences Technology Inc.
  • Stening SRL
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Vascular Concepts Limite
  • WL Gore & Associates, Inc.
Product Code: MRR-1A1A064C03A8

The Airway Stent Market was valued at USD 216.90 million in 2025 and is projected to grow to USD 231.33 million in 2026, with a CAGR of 4.29%, reaching USD 291.20 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 216.90 million
Estimated Year [2026] USD 231.33 million
Forecast Year [2032] USD 291.20 million
CAGR (%) 4.29%

A comprehensive contextual overview clarifying how clinical needs, device innovation, regulatory dynamics, and evolving procurement priorities are reshaping airway stent decision frameworks

The airway stent landscape has matured into a complex intersection of clinical need, technological innovation, and commercial evolution. This introduction sets out the context for decision-makers who must reconcile evolving patient care pathways with device design choices, regulatory considerations, and distribution dynamics. Across clinical settings, from outpatient ambulatory centers to tertiary care hospitals, airway stents are increasingly evaluated not only for immediate procedural outcomes but also for their implications on long-term airway patency, patient quality of life, and downstream care utilization.

In the clinical realm, practitioners are demanding solutions that balance deliverability with durability, biocompatibility with objective efficacy, and tailored performance with streamlined supply chain logistics. Concurrently, materials science is reshaping expectations by enabling devices with enhanced radial force, improved conformability, and, in some cases, controlled drug release profiles. These capabilities are influencing clinician preference and procurement criteria, prompting hospitals and clinics to re-evaluate contracting frameworks and clinical pathways.

From a commercial perspective, manufacturers are navigating a more fragmented purchasing landscape. Distribution models are diversifying, regulatory scrutiny remains elevated, and payer sensitivities are driving more rigorous health-economic conversations. The result is a market environment that rewards clinical differentiation, evidence-based value propositions, and agility in responding to evolving channel strategies. This introduction frames the subsequent analysis by clarifying the essential forces that practitioners, planners, and investors must consider when assessing product development priorities and go-to-market tactics.

How converging advances in device engineering, regulatory expectations, and evolving commercialization models are fundamentally transforming airway stent competitive dynamics and adoption pathways

Over recent years, the airway stent sector has experienced transformative shifts that have altered competitive dynamics and redefined stakeholder expectations. Technological advances in stent design, such as the integration of drug-eluting mechanisms and the refinement of self-expandable architectures, have moved beyond incremental improvements to create new classes of clinical value. These material and engineering innovations are increasingly paired with enhanced imaging, delivery systems, and periprocedural protocols, which together have reduced procedural variability and broadened indications in complex airway pathology.

At the same time, regulatory regimes in key markets have placed a premium on robust clinical evidence and post-market surveillance. This regulatory tightening has elevated the importance of longitudinal outcomes data and has incentivized manufacturers to design studies that demonstrate not only safety but also comparative effectiveness versus established alternatives. Consequently, companies that invest in well-structured clinical programs are gaining enhanced market credibility and stronger positioning with institutional buyers.

Commercial models have evolved in parallel. Distribution channels are becoming more segmented, with direct sales approaches coexisting alongside distributor partnerships and digital platforms. Payers and procurement committees increasingly require transparent cost-effectiveness narratives, and health systems are consolidating purchasing into broader device formularies that favor standardized protocols and trained center-of-excellence networks. In response, firms are prioritizing bundled service offerings, clinician training programs, and data-driven value propositions that align device performance with institutional quality metrics. Overall, the landscape has shifted from product-first competition to ecosystem competition, where clinical evidence, service, and supply reliability are equally decisive.

The 2025 tariff environment has catalyzed strategic supply chain reconfiguration, domestic manufacturing prioritization, and procurement scrutiny across the airway stent ecosystem

The introduction of United States tariffs in 2025 has introduced a discrete layer of commercial and operational complexity for stakeholders across the airway stent value chain. Tariff-induced cost pressures have compelled manufacturers to reassess sourcing strategies for both raw materials and finished components, prompting near-term cost containment measures as well as longer-term supply chain redesigns. For companies reliant on imported metals, polymers, or finished devices, the tariffs have catalyzed a reassessment of supplier diversification, including the exploration of alternative supply bases and increased regional sourcing to mitigate exposure to single-country dependencies.

Supply chain responses have ranged from renegotiated supplier contracts to revisited manufacturing footprints. Some firms accelerated investments in domestic production capabilities to preserve margin and reduce the risk of supply disruptions tied to trade policy volatility. Others absorbed incremental costs in the short term while prioritizing continuity for clinicians and hospitals, relying on pricing and contracting strategies to manage the pass-through of tariff impacts to purchasers. In parallel, procurement teams at hospitals and clinics have intensified scrutiny of total landed cost and supplier risk, incorporating tariff sensitivity into vendor selection and long-term partnership decisions.

Moreover, the tariff environment has influenced strategic partnerships and M&A considerations. Firms with robust in-country manufacturing or diversified global footprints have become more attractive as partners or targets, while pure-play importers faced heightened pressure to demonstrate resilient supply strategies. As a result, the tariff episode has accelerated structural realignments across the industry, with emphasis on operational resilience, flexible sourcing, and transparent cost accounting. For stakeholders, adapting to this environment requires a balanced approach that preserves clinical supply continuity while strategically repositioning procurement, pricing, and production to withstand ongoing geopolitical uncertainty.

Integrated segmentation insights reveal how product type, material composition, end-use environments, and distribution channels shape clinical preference, procurement behavior, and commercialization pathways

A nuanced understanding of market segmentation is essential for aligning product development, clinical evidence generation, and commercial strategies. When analyzed by product type, distinctions among balloon expandable, drug eluting stents, and self expandable devices influence clinician selection criteria, procedural workflows, and adjunctive therapy choices; balloon expandable devices are often favored where controlled deployment and radial force are paramount, drug eluting stents introduce pharmacologic control of restenosis risk and drive evidence needs around elution profiles and systemic exposure, while self expandable designs prioritize conformability and chronic scaffolding in tortuous or dynamic airways. Material choices carry parallel implications: composite, metal, and polymer-based constructions each offer different trade-offs between mechanical performance and biocompatibility. Within metal options, cobalt chromium, nitinol, and stainless steel present a spectrum of elasticity, fatigue resistance, and radiopacity that inform delivery system design and imaging protocols. Polymer options split into biocompatible polymers and bioresorbable polymers, with biocompatible variants often enabling long-term scaffold presence while bioresorbable polymers open pathways for temporary support without permanent implant burden, thereby shifting long-term follow-up and safety considerations.

End-use segmentation further refines go-to-market approaches. Ambulatory surgical centers, clinics, and hospitals create distinct procurement and clinical decision environments: ambulatory surgical centers differentiate into multi-specialty and single procedure models that demand streamlined supply kits and predictable case mix; clinics separate into cardiology and pulmonary specialties, each with unique referral patterns and procedural preferences; hospitals bifurcate into community and tertiary care centers, where community hospitals emphasize cost-effectiveness and ease of use, and tertiary care centers prioritize advanced device features, complex case capability, and robust training support. Distribution channel dynamics interact with these end-use settings, as direct sales, distributors, and e-commerce platforms serve different buyer needs. Distributors operate at national and regional scales and bring logistical reach and value-added services, while e-commerce channels-ranging from OEM platforms to third-party marketplaces-are changing procurement behaviors by offering streamlined ordering, transparent inventory visibility, and alternative pricing models. Integrating these segmentation layers is critical to crafting differentiated product positioning, designing evidence packages that resonate with targeted clinical audiences, and tailoring distribution strategies that match the operational realities of each care setting.

Strategic regional differentiation is essential as distinct regulatory regimes, procurement cultures, and clinical infrastructures across the Americas, EMEA, and Asia-Pacific drive tailored adoption pathways

Regional dynamics exert substantial influence over product adoption, regulatory pathways, and commercial strategies. In the Americas, mature clinical infrastructure and consolidated purchasing organizations drive an emphasis on robust clinical evidence, supply reliability, and cost-effectiveness. U.S. regulatory expectations and hospital procurement practices elevate the value of long-term safety data and streamlined logistics, whereas Latin American markets often prioritize affordability and adaptable service models that account for varying levels of facility capability. Consequently, companies pursuing opportunities in the Americas must balance evidence generation with flexible commercial models that address heterogeneous payer environments and institutional procurement standards.

In Europe, Middle East & Africa, divergent regulatory regimes and healthcare financing models create both challenges and opportunities. Western European markets typically demand rigorous clinical dossiers and have sophisticated hospital networks that value advanced device features and post-market data, while some markets in the Middle East prioritize rapid adoption of proven technologies and offer government-driven procurement pathways. African markets present unique access considerations, including infrastructure limitations and variable regulatory capacity, that favor partnerships, training initiatives, and cost-sensitive offerings. Across EMEA, localization of supply and tailored clinical support programs can materially affect uptake.

The Asia-Pacific region demonstrates heterogeneity driven by rapid technology adoption in some markets and infrastructure variability in others. Countries with advanced tertiary care networks are receptive to innovation and evidence-led adoption, whereas emerging markets emphasize affordability, simplified logistics, and scalable training. Additionally, local manufacturing capabilities and regional trade policies shape sourcing strategies and competitive dynamics. In all regions, cultural nuances in clinician practice patterns and institutional procurement priorities necessitate region-specific value propositions, evidence plans, and distribution models to optimize market penetration and clinical uptake.

Companies that combine advanced device engineering, evidence-based clinical support, and resilient commercial capabilities are securing durable competitive differentiation in the airway stent sector

Leading companies in the airway stent space are distinguishing themselves through integrated strategies that combine product innovation, clinical evidence investment, and commercial execution excellence. Some firms prioritize materials research and device architecture to deliver clinically differentiated performance characteristics that address specific failure modes observed in practice. Others focus on modular delivery systems and clinician training programs that reduce procedural complexity and increase reproducibility across care settings. In parallel, several companies are strengthening post-market evidence and registries to demonstrate long-term outcomes and to support formulary inclusion in major institutions.

Commercially, successful firms are evolving from single-product offerings toward services-oriented models that bundle devices with clinical education, procedural support, and data analytics. This ecosystem approach supports higher adoption in tertiary centers while enabling scaled deployment in ambulatory and community settings. Partnerships with hospital systems and strategic distribution agreements have become pivotal to extending reach and ensuring supply continuity, especially in light of recent trade and tariff dynamics. Moreover, firms that invest in flexible manufacturing footprints and transparent supply chain practices are positioning themselves as lower-risk partners for large health systems and procurement consortia.

In summary, competitive differentiation increasingly rests on the ability to align technical performance with demonstrable clinical value, to operationalize training and support for diverse clinical environments, and to maintain resilient commercial and manufacturing capabilities that satisfy institutional risk and cost criteria.

Actionable strategic priorities for device makers to accelerate adoption through evidence-led innovation, resilient supply chains, tailored commercial models, and payer engagement

Industry leaders should adopt a multi-dimensional strategy that aligns innovation priorities, evidentiary investment, and operational resilience. First, prioritize product development pathways that address documented clinical failure modes while balancing deliverability and long-term biocompatibility. Investing in differentiated material science and delivery mechanisms will help capture clinician preference in both routine and complex procedures. Second, deploy staged clinical evidence programs that begin with pragmatic registries and progress to comparative studies where clinically meaningful differentiation is claimed; these evidence streams will strengthen procurement discussions and support inclusion in institutional device formularies.

Third, reassess supply chain architecture to reduce single-source dependencies and to create redundant capacity where feasible. Strategic investments in regional manufacturing or nearshoring can mitigate tariff exposure and enhance responsiveness. Fourth, tailor commercial models to care settings by offering bundled services and training for tertiary centers while simplifying logistics and kit-based offerings for ambulatory surgical centers and community hospitals. Fifth, embrace digital channels for order management and clinician engagement, ensuring e-commerce platforms and OEM portals improve procurement transparency and inventory reliability.

Finally, cultivate collaborative relationships with payers and clinical leaders to articulate clear value propositions centered on patient outcomes and total cost of care. By combining technical innovation with rigorous evidence, resilient operations, and pragmatic commercial approaches, industry leaders can sustain growth while addressing stakeholder demands across diverse care settings.

A rigorous mixed-methods research approach combining clinician interviews, procurement insights, regulatory analysis, and product technical review to validate actionable strategic inferences

This report synthesizes primary and secondary research methodologies to construct a holistic view of the airway stent landscape. Primary inputs included structured interviews with clinicians across pulmonology and interventional specialties, procurement leaders from hospitals and ambulatory centers, and supply chain executives spanning manufacturing and distribution. These engagements were designed to elicit practical insights on device performance priorities, procurement criteria, and operational constraints that influence adoption decisions. Secondary research encompassed regulatory guidance documents, clinical literature, and product technical specifications to contextualize technological trends and safety considerations.

Analytical techniques incorporated qualitative thematic analysis of stakeholder interviews and cross-sectional comparison of device attributes and clinical evidence. Where applicable, sensitivity analyses explored the operational impact of supply chain variables and tariff scenarios on procurement preferences, while case studies illustrated how leading institutions evaluate and integrate airway stent technologies into care pathways. Throughout the methodology, validity checks were implemented via triangulation across data sources and peer review by clinical advisors to ensure robustness. The approach emphasizes transparent sourcing of insights and careful differentiation between empiric observations and strategic implications so that decision-makers can apply conclusions with confidence.

Synthesis of technical, regulatory, and commercial imperatives that will determine which organizations succeed in translating airway stent innovation into sustained clinical and institutional impact

In conclusion, the airway stent sector is at a pivotal juncture where device innovation, clinical evidence expectations, and commercial dynamics converge to redefine adoption pathways. Advances in materials and design are expanding therapeutic options, while regulatory and procurement environments are increasingly tied to demonstrable long-term outcomes and value-based narratives. The tariff environment and shifting distribution paradigms have underscored the importance of resilient supply chains and flexible commercialization models.

Looking ahead, organizations that integrate targeted product differentiation with pragmatic evidence strategies, regionalized operational resilience, and tailored commercial execution will be best positioned to meet the varied needs of ambulatory centers, clinics, and hospitals. Collaboration across clinical, manufacturing, and procurement stakeholders will be essential to translate technological promise into measurable patient benefit. By focusing on these aligned priorities, manufacturers and institutional partners can navigate current headwinds and unlock sustainable opportunities for improved airway management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Airway Stent Market, by Product Type

  • 8.1. Balloon Expandable
  • 8.2. Drug Eluting Stents
  • 8.3. Self Expandable

9. Airway Stent Market, by Material

  • 9.1. Composite
  • 9.2. Metal
    • 9.2.1. Cobalt Chromium
    • 9.2.2. Nitinol
    • 9.2.3. Stainless Steel
  • 9.3. Polymer
    • 9.3.1. Biocompatible Polymer
    • 9.3.2. Bioresorbable Polymer

10. Airway Stent Market, by End Use

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Multi Specialty
    • 10.1.2. Single Procedure
  • 10.2. Clinics
    • 10.2.1. Cardiology Clinics
    • 10.2.2. Pulmonary Clinics
  • 10.3. Hospitals
    • 10.3.1. Community Hospitals
    • 10.3.2. Tertiary Care

11. Airway Stent Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Distributors
    • 11.2.1. National
    • 11.2.2. Regional
  • 11.3. E Commerce
    • 11.3.1. OEM Platforms
    • 11.3.2. Third Party Platforms

12. Airway Stent Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Airway Stent Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Airway Stent Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Airway Stent Market

16. China Airway Stent Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Allium Medical Solutions Ltd.
  • 17.6. Becton Dickinson and Company
  • 17.7. Boston Scientific Corporation
  • 17.8. Bryan Corporation
  • 17.9. BVM Medical Limited
  • 17.10. Cook Medical
  • 17.11. Ella-CS
  • 17.12. EndoFlex GmbH
  • 17.13. Hood Laboratories
  • 17.14. Leufen Medical GmbH
  • 17.15. Medi-Globe Corporation
  • 17.16. Merit Medical Systems Inc.
  • 17.17. Micro-Tech Endoscopy Co., Ltd.
  • 17.18. Novatech SA
  • 17.19. Olympus Corporation
  • 17.20. PFM Medical
  • 17.21. Pnn Medical A/S
  • 17.22. S&G Biotech
  • 17.23. Sino Medical Sciences Technology Inc.
  • 17.24. Stening SRL
  • 17.25. Taewoong Medical Co., Ltd.
  • 17.26. Teleflex Incorporated
  • 17.27. Vascular Concepts Limite
  • 17.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AIRWAY STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AIRWAY STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AIRWAY STENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AIRWAY STENT MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AIRWAY STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AIRWAY STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AIRWAY STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AIRWAY STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AIRWAY STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AIRWAY STENT MARKET SIZE, BY BALLOON EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AIRWAY STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AIRWAY STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AIRWAY STENT MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AIRWAY STENT MARKET SIZE, BY SELF EXPANDABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AIRWAY STENT MARKET SIZE, BY SELF EXPANDABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AIRWAY STENT MARKET SIZE, BY SELF EXPANDABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AIRWAY STENT MARKET SIZE, BY COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AIRWAY STENT MARKET SIZE, BY COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AIRWAY STENT MARKET SIZE, BY COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AIRWAY STENT MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AIRWAY STENT MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AIRWAY STENT MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AIRWAY STENT MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AIRWAY STENT MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AIRWAY STENT MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AIRWAY STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AIRWAY STENT MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AIRWAY STENT MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AIRWAY STENT MARKET SIZE, BY BIOCOMPATIBLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AIRWAY STENT MARKET SIZE, BY BIOCOMPATIBLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AIRWAY STENT MARKET SIZE, BY BIOCOMPATIBLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AIRWAY STENT MARKET SIZE, BY BIORESORBABLE POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AIRWAY STENT MARKET SIZE, BY BIORESORBABLE POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AIRWAY STENT MARKET SIZE, BY BIORESORBABLE POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AIRWAY STENT MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AIRWAY STENT MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AIRWAY STENT MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AIRWAY STENT MARKET SIZE, BY SINGLE PROCEDURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AIRWAY STENT MARKET SIZE, BY SINGLE PROCEDURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AIRWAY STENT MARKET SIZE, BY SINGLE PROCEDURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AIRWAY STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AIRWAY STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AIRWAY STENT MARKET SIZE, BY CARDIOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AIRWAY STENT MARKET SIZE, BY PULMONARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AIRWAY STENT MARKET SIZE, BY PULMONARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AIRWAY STENT MARKET SIZE, BY PULMONARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AIRWAY STENT MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AIRWAY STENT MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AIRWAY STENT MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AIRWAY STENT MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AIRWAY STENT MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AIRWAY STENT MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AIRWAY STENT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AIRWAY STENT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AIRWAY STENT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AIRWAY STENT MARKET SIZE, BY NATIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AIRWAY STENT MARKET SIZE, BY NATIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AIRWAY STENT MARKET SIZE, BY NATIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AIRWAY STENT MARKET SIZE, BY REGIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AIRWAY STENT MARKET SIZE, BY REGIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AIRWAY STENT MARKET SIZE, BY REGIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AIRWAY STENT MARKET SIZE, BY OEM PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AIRWAY STENT MARKET SIZE, BY OEM PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AIRWAY STENT MARKET SIZE, BY OEM PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AIRWAY STENT MARKET SIZE, BY THIRD PARTY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL AIRWAY STENT MARKET SIZE, BY THIRD PARTY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL AIRWAY STENT MARKET SIZE, BY THIRD PARTY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL AIRWAY STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS AIRWAY STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL AIRWAY STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 204. GCC AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. GCC AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 208. GCC AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 209. GCC AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 213. GCC AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. GCC AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. G7 AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 244. G7 AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 246. G7 AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. G7 AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 250. G7 AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 251. G7 AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 255. NATO AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. NATO AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL AIRWAY STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA AIRWAY STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA AIRWAY STENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA AIRWAY STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA AIRWAY STENT MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA AIRWAY STENT MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA AIRWAY STENT MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA AIRWAY STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA AIRWAY STENT MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA AIRWAY STENT MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA AIRWAY STENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA AIRWAY STENT MARKET SIZE, BY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA AIRWAY STENT MARKET SIZE, BY E COMMERCE, 2018-2032 (USD MILLION)